Tag: GILD

Gilead Sciences, Inc. has successfully completed the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its cash ...

On January 24, 2024, the U.S. Food and Drug Administration (FDA) made a significant announcement regarding chimeric antigen receptor T-cell ...